Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-20-047619

SVP & General Counsel sold 1,529 shares at $19.67 ($30,075)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wilson Mark Andrew SVP & General Counsel 2020-08-17 Sale −1,529 $19.67 $30,075 51,389 D: show line 1 in the form
Open-market sales · 1,529 sh · avg $19.67 · $30,075
Loading xslF345X03/doc4.xml…